Publication:
Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6

dc.contributor.authorBrioschi Guevara, Andrea
dc.contributor.authorBieler, Melanie
dc.contributor.authorAltomare, Daniele
dc.contributor.authorBerthier, Marcelo
dc.contributor.authorCsajka, Chantal
dc.contributor.authorDautricourt, Sophie
dc.contributor.authorDémonet, Jean-François
dc.contributor.authorDodich, Alessandra
dc.contributor.authorFrisoni, Giovanni B.
dc.contributor.authorMiniussi, Carlo
dc.contributor.authorMolinuevo, José Luis
dc.contributor.authorRibaldi, Federica
dc.contributor.authorScheltens, Philip
dc.contributor.authorChételat, Gael
dc.contributor.authoraffiliation[Brioschi Guevara,A; Bieler,M; Démonet,JF] Centre Leenaards de la Mémoire, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. [Altomare,D; Frisoni,GB; Ribaldi,F] Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland. [Altomare,D; Frisoni,GB; Ribaldi,F] Memory Clinic, Geneva University Hospitals, Geneva, Switzerland. [Berthier,M] Unit of Cognitive Neurology and Aphasia, Centro de Investigaciones Médico-Sanitarias, University of Malaga, Malaga, Spain. [Berthier,M] Instituto de Investigación Biomédica de Málaga – IBIMA, Malaga, Spain. [Csajka,C] Center for Research and Innovation in clinical Pharmaceutical Sciences, University Hospital and University of Lausanne, Lausanne, Switzerland. [Csajka,C] School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland. [Csajka,C] Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Geneva, Switzerland. [Dautricourt,S; Chételat,G] Normandie Univ, UNICAEN, INSERM, PhIND “Physiopathology and Imaging of Neurological Disorders”, Institut Blood and Brain @ Caen-Normandie, Cyceron, France. [Dodich,A; Miniussi,C] Center for Mind/ Brain Sciences – CIMeC, University of Trento, Rovereto, Italy. [Molinuevo,JL] Barcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain. [Ribaldi,F] Laboratory of Alzheimer’s Neuroimaging and Epidemiology (LANE), Saint John of God Clinical Research Centre, Brescia, Italy. [Ribaldi,F] Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. [Scheltens,P] Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit.
dc.date.accessioned2024-02-19T15:31:41Z
dc.date.available2024-02-19T15:31:41Z
dc.date.issued2021-10-11
dc.description.abstractCognitive complaints in the absence of objective cognitive impairment, observed in patients with subjective cognitive decline (SCD), are common in old age. The first step to postpone cognitive decline is to use techniques known to improve cognition, i.e., cognitive enhancement techniques.We aimed to provide clinical recommendations to improve cognitive performance in cognitively unimpaired individuals, by using cognitive, mental, or physical training (CMPT), non-invasive brain stimulations (NIBS), drugs, or nutrients. We made a systematic review of CMPT studies based on the GRADE method rating the strength of evidence.CMPT have clinically relevant effects on cognitive and non-cognitive outcomes. The quality of evidence supporting the improvement of outcomes following a CMPT was high for metamemory; moderate for executive functions, attention, global cognition, and generalization in daily life; and low for objective memory, subjective memory, motivation, mood, and quality of life, as well as a transfer to other cognitive functions. Regarding specific interventions, CMPT based on repeated practice (e.g., video games or mindfulness, but not physical training) improved attention and executive functions significantly, while CMPT based on strategic learning significantly improved objective memory.We found encouraging evidence supporting the potential effect of NIBS in improving memory performance, and reducing the perception of self-perceived memory decline in SCD. Yet, the high heterogeneity of stimulation protocols in the different studies prevent the issuing of clear-cut recommendations for implementation in a clinical setting. No conclusive argument was found to recommend any of the main pharmacological cognitive enhancement drugs ("smart drugs", acetylcholinesterase inhibitors, memantine, antidepressant) or herbal extracts (Panax ginseng, Gingko biloba, and Bacopa monnieri) in people without cognitive impairment.Altogether, this systematic review provides evidence for CMPT to improve cognition, encouraging results for NIBS although more studies are needed, while it does not support the use of drugs or nutrients.
dc.description.sponsorshipThis paper was the product of a workshop funded by the Swiss National Science Foundation entitled “Dementia Prevention Services” (grant number: IZSEZ0_193593). GBF received funding by: the EU-EFPIA Innovative Medicines Initiatives 2 Joint Undertaking (IMI 2 JU) “European Prevention of Alzheimer’s Dementia consortium” (EPAD, grant agreement number: 115736) and “Amyloid Imaging to Prevent Alzheimer’s Disease” (AMYPAD, grant agreement number: 115952); the Swiss National Science Foundation: “Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): correlation with clinical features and in vivo neuropathology” (grant number: 320030_182772).
dc.identifier.doi10.1186/s13195-021-00844-1
dc.identifier.e-issn1758-9193es_ES
dc.identifier.journalAlzheimer's Research & Therapyes_ES
dc.identifier.otherhttp://hdl.handle.net/10668/3748
dc.identifier.pubmedID34635149es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18481
dc.language.isoeng
dc.publisherBioMed Central (BMC)
dc.relation.publisherversionhttps://alzres.biomedcentral.com/articles/10.1186/s13195-021-00844-1es
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectSubjective cognitive decline
dc.subjectCognitive enhancement
dc.subjectCognitive intervention
dc.subjectMindfulness meditation
dc.subjectPhysical training
dc.subjectNon-invasive brain stimulation
dc.subjectDrugs
dc.subjectBrain health service
dc.subjectDisfunción cognitiva
dc.subjectAtención plena
dc.subjectMeditación
dc.subjectAcondicionamiento físico
dc.subject.meshAcetylcholinesterase
dc.subject.meshBrain
dc.subject.meshClinical Protocols
dc.subject.meshAntidepressive Agents
dc.subject.meshGinkgo biloba
dc.subject.meshHumans
dc.subject.meshQuality of Life
dc.subject.meshAcetylcholinesterase
dc.subject.meshMemantine
dc.subject.meshMemory Disorders
dc.titleProtocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6
dc.typereview article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isPublisherOfPublication4fe896aa-347b-437b-a45b-95f4b60d9fd3
relation.isPublisherOfPublication.latestForDiscovery4fe896aa-347b-437b-a45b-95f4b60d9fd3

Files